Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Meets Primary and Secondary Endpoints in Placebo-Controlled U.S. Phase 2 Clinical Trial for the Treatment of Adult Patients with Rett Syndrome
https://www.anavex.com/anavex-life-...he-treatment-of-adult-patients-with-rett-syn/
- Forums
- ASX - By Stock
- ANAVEX MEETS ENDPOINTS PHASE2 RETT
Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Meets...
- There are more pages in this discussion • 166 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$20.71 |
Change
0.000(0.00%) |
Mkt cap ! $2.644B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 297 | $21.74 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.37 | 10 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 297 | 21.740 |
1 | 500 | 21.500 |
1 | 50 | 21.120 |
2 | 23031 | 21.000 |
4 | 132 | 20.910 |
Price($) | Vol. | No. |
---|---|---|
20.370 | 10 | 1 |
20.500 | 148 | 3 |
20.690 | 350 | 1 |
20.710 | 100 | 2 |
20.800 | 973 | 7 |
Last trade - 15.06pm 23/05/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
Day chart unavailable